S&P 500Dow JonesNASDAQ 100DAX 40MDAXSDAXTecDAXATXSMICAC 40AEXBEL 20IBEX 35
Home/MDAX/Carl Zeiss Meditec
Carl Zeiss Meditec

Carl Zeiss Meditec

AFX.DEMDAX
30,50 €
Dividend yield1,80 %
Continuity22 yr
Dividend0,55 €
ISINDE0005313704
DiviScore
45SCORERisk
Performance5/35
Dividend Quality25/35
AGM Date
26.03.2026
Ex-Date
27.03.2026
Payment
31.03.2026
CAGR 3Y
-33.4%
CAGR 5Y
-30.5%
CAGR 10Y
-0.9%

€10,000 invested in 2016 · with dividend reinvestment

+1%
End Value
10.088,15 €
Total Return
+0.9%
Annual Return
0.1% p.a.
Dividends Received
2.334,56 €

Dividend history

22 years continuous
YearAmountDividend yieldAGM dateEx-datePayment dateChange
20260,55 €26.03.202627.03.202631.03.2026-8.3%
20250,60 €26.03.202527.03.202531.03.20250.0%
20240,60 €26.03.202527.03.202531.03.2025-45.5%
20231,10 €21.03.202422.03.202426.03.20240.0%
20221,10 €22.03.202323.03.202327.03.2023+22.2%
20210,90 €30.03.202231.03.202204.04.2022+80.0%
20200,50 €27.05.202128.05.202101.06.2021-23.1%
20190,65 €08.07.202007.08.202006.09.2020+18.2%
20180,55 €18.02.201920.03.201919.04.20190.0%
20170,55 €12.03.201811.04.201811.05.2018+31.0%

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a leading medical technology company specializing in ophthalmology and microsurgery solutions. Headquartered in Jena, Germany, and founded in 1846, it operates as a subsidiary of the ZEISS Group, delivering innovative products for diagnosing and treating eye diseases such as ametropia, cataracts, glaucoma, and retinal disorders. Its Ophthalmology segment provides diagnostic tools like slit lamps, refractometers, optical coherence tomography devices, and fundus cameras, alongside surgical equipment including microscopes, biometers, phacoemulsification systems, vitrectomy devices, intraocular lenses, and laser surgery consumables. The Microsurgery segment offers visualization and treatment solutions for neurosurgery, ear-nose-throat procedures, spine, plastic and reconstructive surgery, and dentistry. With a global presence across Europe, North America, and Asia, employing over 5,700 people, Carl Zeiss Meditec AG drives advancements in healthcare through cutting-edge technologies, digital workflow solutions, and AI-integrated systems, enhancing clinical efficiency and patient outcomes in advanced medical equipment sectors.

IndustryMedical Instruments & Supplies
SectorHealthcare
KGV (PE)22.20
Payout Ratio43.8%
ROE4.5%

Frequently Asked Questions

The next payment date is 31.03.2026.
Carl Zeiss Meditec has a DiviScore of 45/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Carl Zeiss Meditec's current dividend yield is 1.80% based on the latest dividend.
Carl Zeiss Meditec (AFX.DE) is a member of MDAX. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.